Vivex Biologics has completed enrollment in its ASCEND trial testing VIA Disc NP, a minimally invasive therapy for degenerative disc disease. Results expected Q1 2026.
#News #ClinicalTrial #BackPainRelief #DegenerativeDiscDisease #SpineHealth #VIVEX #VIA DiscNP #PainManagement
0
0
0
0